Metabolic disorder of pregnancy (understanding pathophysiology of diabetes and preeclampsia)

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 29, Issue 3, 2015, Pages 328-338

  Salzer, Liat ^a,b   Tenenbaum Gavish, Kinneret ^a,b   Hod, Moshe ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Gestational diabetes; Gestational hypertension; Insulin resistance; Obesity; Pathogenesis

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADVANCED OXIDATION PROTEIN PRODUCT; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; BLOOD CLOTTING FACTOR 8; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; FATTY ACID; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 4; FETAL ANTIGEN; GLUCOSE; HLA ANTIGEN; HORMONE SENSITIVE LIPASE; HUMAN PLACENTA LACTOGEN; HYDROCORTISONE; INSULIN; LEPTIN; LIPID HYDROPEROXIDE; MALONALDEHYDE; MYELOPEROXIDASE; PLACENTAL GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN; THROMBOXANE; TRIACYLGLYCEROL; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ARTICLE; CARBOHYDRATE INTOLERANCE; CESAREAN SECTION; ELEVATED BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; FIRST TRIMESTER PREGNANCY; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE UTILIZATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LIPOLYSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MATERNAL HYPERTENSION; MATERNAL OBESITY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; REPRODUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM RETENTION; SYMPATHETIC TONE; THIRD TRIMESTER PREGNANCY; TRISOMY 13; URINARY TRACT INFECTION; WEIGHT GAIN; FEMALE; HYPERINSULINISM; HYPERTENSION; METABOLISM; PREGNANCY; PREGNANCY COMPLICATION;

DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERINSULINISM; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84933516471     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2014.09.008     Document Type: Article

References (93)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988 37 12 1595-607.
2. Carpenter MW. Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care 2007;30(Suppl. 2):S246-50.
3. Yogev Y, Bene Haroush A, Chen R, et al. Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. Am J Obstet Gynecol 2004 Sep; 191(3):949-53.
4. Practice Committee of American Society for Reproductive Medicine. Obesity and reproduction: an educational bulletin. Fertil Steril 2008;90 (5 Suppl). S2.
5. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008 29 2959-71.
6. O'Sullivan JB, Mahan C. Criteria for oral glucose tolerance test in pregnancy. Diabetes 1964 13 278-85.
7. Bergman RN, Ider YZ, Bowden CR, et al. Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236:E667-77.
8. Catalano PM, Huston L, Amini SB, et al. Longitudinal change in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999 180 903-16.
9. Ryan EA, Ennes L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 1988 67 341-7.
10. Catalano PM, Tyzbir ED, Wolfe RR, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 1993;264(1 Pt 1):E60-7.
11. Ward WK, Johnston CL, Beard JC, et al. Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes 1985 34 9 861-9.
12. Radaelli T, Farrell KA, Hustone Presley L, et al. Estimates of insulin sensitivity using glucose and CePeptide from the hye perglycemia and adverse pregnancy outcome glucose tolerance test. Diabetes Care 2010 33 3 490-4.
13. The HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcomes. N Engl J Med May 8, 2008 2008 358 1991-2002.
14. Hauguel S, Leturque A, Gilbert M, et al. Effects of pregnancy and fasting on muscle glucose utilization in the rabbit. Am J Obstet Gynecol 1988 158 1215-8.
15. Leturque A, Ferre P, Burnol AF, et al. Glucose utilization rates and insulin sensitivity in vivo in tissues of virgin and pregnant rats. Diabetes 1986 35 172-7.
16. Gibson M, Tulchinski D. The maternal adrenal. In: Tulchinski D, Ryan KJ, editors. Maternalefetal endocrinology. Philadelphia: WB Saunders; 1980. p. 129-43.
17. Ahmed SA, Shalayel MH. Role of cortisol in the deterioration of glucose tolerance in Sudanese pregnant women. East Afr Med J 1999 76 465-7.
18. Rizza RA, Mandarino LJ, Gerich JE. Cortisol induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. Clin Endocrinol Metab 1982 54 131-8.
19. Highman TJ, Friedman JE, Huston LP, et al. Longitudinal changes in maternal serum leptin concentrations body composition and resting metabolic rate in pregnancy. Am J Obstet Gynecol 1999 178 1010-5.
20. Henson MC, Swan KF, O'Neil JS. Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term. Obstet Gynecol 1998 92 1020-8.
21. Kautzkye Willer A, Pacini G, Tura A, et al. Increased plasma leptin in gestational diabetes. Diabetologia 2001 44 164-72.
22. Vitoratos N, Salamalekis E, Kassanos D, et al. Maternal plasma leptin levels and their relationship to insulin and glucose in gestationaleonset diabetes. Gynecol Obstet Invest 2001 51 17-21.
23. Beck P, Daughday WH. Human placental lactogen: studies of its acute metabolic effects and disposition in normal man. J Clin Invest 1967 46 103-10.
24. Kühl C. Aetiology of gestational diabetes. Baillieres Clin Obstet Gynaecol 1991 Jun; 5(2):279-92.
25. Lind T, Billewicz WZ, Brown G. A serial study of changes occurring in the oral glucose tolerance test during pregnancy. J Obstet Gynaecol Br Commonw 1973 80 12 1033-9.
26. Gustafson AB, Banasiak MF, Kalkhoff RK. Correlation of hyperprolactinemia with altered plasma insulin and glucose: similarity to effects of late human pregnancy. J Clin Endocrinol Metab 1980 51 242-6.
27. Sorenson RL, Brelje TC, Roth C. Effect of steroid and lactogenic hormones on islet of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy. Endocrinology 1993 133 2227-33.
28. Skouby SO, Kuhl C, Hornnes PJ, et al. Prolactin and glucose tolerance in normal and gestational diabetic pregnancy. Obstet Gynecol 1986 67 17-20.
29. Brelje TC, Scharp DW, Lacy PE, et al. Effect of homologous placental lactogens, prolactins, and growth hormones on islet Becell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology 1993 132 879-87.
30. Herrera E, Ortegae Senovilla H. Disturbances in lipid metabolism in diabetic pregnancy e are these the cause of the problem? Best Pract Res Clin Endocrinol Metab 2010 Aug; 24(4):515e25. http://dx.doi.org/10.1016/j.beem.2010.05.006.
31. Darmady J, Postle A. Lipid metabolism in pregnancy. BJOG 1982 89 211-5.
32. Sivan E, Homko C, Chen X, et al. Effect of insulin on fat metabolism during and after normal pregnancy. Diabetes 1999 48 834-8.
33. Catalano PM, Nizielski S, Shao J, et al. Down regulation of IRSe1 and PPARgamma in obese women with gestational diabetes: relationship to free fatty acids during pregnancy. Am J Physiol Endocrinol Metab 2002;282(3):E522-33.
34. Montelongo A, Lasuncion M, Pallardo L, et al. Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes 1992 41 1651-9.
35. Koukkou E, Watts GF, Lowy C. Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a crossesectional and prospective study. J Clin Pathol 1996 49 634-7.
36. Coe NR, Bernlohr DA. Physiological properties and functions of intracellular fatty acidebinding proteins. Biochim Biophys Acta 1998 1391 287-306.
37. Smith AJ, Thompson BR, Sanders MA, et al. Interaction of the adipocyte fatty acidebinding protein with the hormonee sensitive lipase: regulation by fatty acids and phosphorylation. J Biol Chem 2007 282 32424-32.
38. Ortegae Senovilla H, Schaefere Graf U, Meitzner K, et al. Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acidebinding protein and other adipocytokines in cord blood. Diabetes Care Sep. 2011;34(9):2061-6.
39. Retnakaran R, Hanley AJ, Raif N, et al. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 2004 Mar; 27(3):799-800.
40. Schmatz M, Madan J, Marino T, et al. Maternal obesity: the interplay between inflammation, mother and fetus. J Perinatol 2010 30 441-6.
41. Fujita K, Nishizawa H, Funahashi T, et al. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006 70 1437-42.
42. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004 114 1752-61.
43. Karacay O, Sepicie Dincel A, Karcaaltincaba D, et al. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation. N Diabetes Res Clin Pract 2010 Sep; 89(3):231-8.
44. Vikse BE, Irgens LM, Leivestad T, et al. Preeclampsia and the risk of endestage renal disease. N Engl J Med 2008 359 800.
45. Levine RJ, Vatten LJ, Horowitz GL, et al. Preeeclampsia, soluble fmselike tyrosine kinase 1, and the risk of reduced thyroid function: nested caseecontrol and population based study. BMJ 2009;339:b4336.
46. Xia Y, Wen H, Bobst S, et al. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Investig 2003 10 82.
47. Dechend R, Homuth V, Wallukat G, et al. AT (1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 2000 101 2382.
48. Zhou CC, Ahmad S, Mi T, et al. Autoantibody from women with preeclampsia induces soluble Fmselike tyrosine kinasee1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated Tecells signaling. Hypertension 2008 51 1010.
49. Friedman SA, Schiff E, Emeis JJ, et al. Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol 1995 172 202.
50. Hsu CD, Iriye B, Johnson TR, et al. Elevated circulating thrombomodulin in severe preeclampsia. Am J Obstet Gynecol 1993 169 148.
51. Taylor RN, Crombleholme WR, Friedman SA, et al. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol 1991 165 895.
52. Howard G, O'Leary DH, Zaccaro D, et al. Insulin sensitivity and atherosclerosis. Circulation 1996 93 10 1809-17.
53. Caruso A, Ferrazzani S, De Carolis S, et al. Gestational hypertension but not preeeclampsia is associated with insulin resistance syndrome characteristics. Hum Reprod 1999 14 1 219-23.
54. Solomon CG, Graves SW, Green MF, et al. Glucose intolerance as a predictor of hypertension in pregnancy. Hypertension 1994;23(6 Pt 1):717-21.
55. Bdolah Y, Lam C, Rajakumar A, et al. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am J Obstet Gynecol 2008;198. 428.e1.
56. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006 12 642.
57. Luft FC. Soluble endoglin (sEng) joins the soluble fmselike tyrosine kinase (sFlt) receptor as a preeeclampsia molecule. Nephrol Dial Transplant 2006 21 3052.
58. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991 4 700.
59. Harskamp RE, Zeeman GG. Preeclampsia: at risk for remote cardiovascular disease. Am J Med Sci 2007 334 291.
60. Kaaja R, Laivuori H, Laakso M, et al. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism 1999 48 7 892-6.
61. Wolf M, Sandler L, Munoz K, et al. First trimester insulin resistance and subsequent preeclampsia: a prospective study. Clin Endocrinol Metab 2002 87 4 1563-8.
62. Srinivas SK, Sammel MD, Bastek J, et al. Evaluating the association between all components of the metabolic syndrome and preeeclampsia. J Matern Fetal Neonatal Med 2009 22 6 501-9.
63. Ray JG, Diamond P, Singh G, et al. Brief overview of maternal triglycerides as a risk factor for preeeclampsia. BJOG 2006 113 4 379-86.
64. Sermer M, Naylor CD, Gare DJ, et al. Impact of increasing carbohydrate intolerance on maternalefetal outcomes in 3637 women without gestational diabetes: The Toronto Trihospital Gestational Project. Am J Obstet Gynecol 1995 173 146-56.
65. Hjartardottir S, Leifsson BG, Geirsson RT, et al. Recurrence of hypertensive disorder in second pregnancy. Am J Obstet Gynecol 2006 194 916.
66. Brown MA, Mackenzie C, Dunsmuir W, et al. Can we predict recurrence of preeeclampsia or gestational hypertension? BJOG 2007 114 984.
67. Villar J, Carroli G, Wojdyla D, et al., World Health Organization Antenatal Care Trial Research Group. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 2006 194 921.
68. Tu W, Eckert GJ, Di Meglio LA, et al. Intensified effect of adiposity on blood pressure in overweight and obese children. Hypertension 2011 58 818.
69. Wilson PW, D'Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: the Frae mingham experience. Arch Intern Med 1867 2002 162.
70. Nugent CE, Punch MR, Barr Jr M, et al. Persistence of partial molar placenta and severe preeclampsia after selective termination in a twin pregnancy. Obstet Gynecol 1996 87 829.
71. Meekins JW, Pijnenborg R, Hanssens M, et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe preeeclamptic pregnancies. Br J Obstet Gynaecol 1994 101 669.
72. Brosens I, Pijnenborg R, Vercruysse L, et al. The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol 2011 204 193.
73. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179(5):1359-75.
74. Dekker GA. Risk factors for preeclampsia. Clin Obstet Gynecol 1999 42 422.
75. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997 2152 99.
76. Zhou Y, Gormley MJ, Hunkapiller NM, et al. Reversal of gene dysregulation in cultured cytotrophoblasts reveals possible causes of preeclampsia. J Clin Invest 2013 123 2862.
77. Einarsson JI, Sangie Haghpeykar H, Gardner MO. Sperm exposure and development of preeclampsia. Am J Obstet Gynecol 2003 188 1241.
78. Smith GN, Walker M, Tessier JL, et al. Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility. Am J Obstet Gynecol 1997 177 455.
79. Wang JX, Knottnerus AM, Schuit G, et al. Surgically obtained sperm, and risk of gestational hypertension and pree eclampsia. Lancet 2002 359 673.
80. Gleicher N. Why much of the pathophysiology of preeclampsiaeeclampsia must be of an autoimmune nature. Am J Obstet Gynecol 2007;196. 5.e1.
81. Saftlas AF, Beydoun H, Triche E. Immunogenetic determinants of preeclampsia and related pregnancy disorders: a systematic review. Obstet Gynecol 2005 106 162.
82. Lachmeijer AM, Dekker GA, Pals G, et al. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 2002 105 94.
83. Germain SJ, Sacks GP, Sooranna SR, et al. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007 178 5949.
84. Condee Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metae analysis. Am J Obstet Gynecol 2008 Jan; 198(1):7e22. http://dx.doi.org/10.1016/j.ajog.2007.07.040.
85. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004 350 672.
86. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fmselike tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003 111 649.
87. McKeeman GC, Ardill JE, Caldwell CM, et al. Soluble vascular endothelial growth factor receptore1 (sFlte1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol 2004 191 1240.
88. Huang Z, Willett WC, Manson JE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med 1998 128 81.
89. Carr DB, Epplein M, Johnson CO, et al. A sister's risk: family history as a predictor of preeclampsia. Am J Obstet Gynecol 2005 193 965.
90. Treloar SA, Cooper DW, Brennecke SP, et al. An Australian twin study of the genetic basis of preeclampsia and eclampsia. Am J Obstet Gynecol 2001 184 374.
91. Rocchini AP, Katch V, Kveselis D, et al. Insulin and renal sodium retention in obese adolescents. Hypertension 1989 14 367.
92. Kincaide Smith P. Hypothesis: obesity and the insulin resistance syndrome play a major role in endestage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'. J Hypertens 2004 22 1051.
93. Mooree Maxwell CA, Robboy SJ. Placental site trophoblastic tumor arising from antecedent molar pregnancy. Gynecol Oncol 2004 92 708.